✦ LIBER ✦

Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study

✍ Scribed by Daniel Glicklich; Roberto Gordillo; Katarina Supe; Raquel Tapia; Robert Woroniecki; Clemencia Solorzano; Maria Coco

Book ID: 110890489
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 112 KB
Volume: 25
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2010.01372.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of simvastatin for h

Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study

✍ A.F Santos; E Keitel; A.E Bittar; J Neumann; F.D Fuchs; J.C Goldani; N.A Fonseca 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Effects of amlodipine, nifedipine GITS,

Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: A randomized, placebo-controlled, double-masked, crossover study

✍ Roberto Fogari; Annalisa Zoppi; Amedeo Mugellini; Paola Preti; Alessandra Bander 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 560 KB

A double-blind study to compare the effi

A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo

✍ Alberto S. Villamil; Victoria Cairns; Peter U. Witte; Carlos A. Bertolasi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Prevention of vascular damage in sclerod

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril

✍ A. E. Gliddon; C. J. Doré; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t

A 16-week, randomized, double-blind, pla

A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a β-blocker on blood pressure reduction

✍ David S. Wald; Malcolm Law; Sarah Mills; Jonathan P. Bestwick; Joan K. Morris; N 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 882 KB

A randomized, double-blind comparative s

A randomized, double-blind comparative study of the effects on potassium and aldosterone of two commonly used angiotensin-converting enzyme inhibitors (ACEI): W. Yu, T. Keilard, H; Felmi, W. Schlueter, and D. Batlle. Division of Nephrology, Northwestern University School of Medicine, Lakeside VA Medical Center, Chicago, Illinois

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB